Lumentum Q2 Earnings Forecast Raised by Northland Securities

Lumentum Holdings Inc. (NASDAQ:LITE) – Analysts at Northland Securities lifted their Q2 2027 EPS estimates for Lumentum in a research report issued on Tuesday, November 3rd. Northland Securities analyst T. Savageaux now anticipates that the technology company will post earnings of $4.85 per share for the quarter, up from their prior estimate of $4.63. The consensus estimate for Lumentum’s current full-year earnings is $19.93 per share. Northland Securities also issued estimates for Lumentum’s Q3 2027 earnings at $5.33 EPS and Q4 2027 earnings at $5.83 EPS.

Lumentum (NASDAQ:LITE) last issued its quarterly earnings data on Monday, November 2nd. The technology company reported $4.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.22 by $0.35. Lumentum had a negative net margin of 175.82% and a positive return on equity of 28.85%. The company had revenue of $1.26 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the firm earned $1.10 earnings per share. The firm’s revenue was up 136.5% compared to the same quarter last year.

Other research analysts also recently issued reports about the company. Needham & Company LLC decreased their price objective on Lumentum from $1,040.00 to $800.00 and set a “buy” rating for the company in a report on Tuesday, November 3rd. Weiss Ratings cut Lumentum from a “hold (c-)” rating to a “sell (d-)” rating in a research note on Wednesday, August 19th. Evercore started coverage on Lumentum in a research note on Monday, August 31st. They issued an “outperform” rating and a $1,100.00 target price on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on Lumentum in a research report on Monday, August 31st. They set a “buy” rating and a $1,200.00 price target for the company. Finally, Raymond James Financial raised shares of Lumentum from a “moderate buy” rating to a “strong-buy” rating and set a $1,328.00 price target for the company in a research note on Monday, November 2nd. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Lumentum presently has an average rating of “Moderate Buy” and a consensus target price of $1,053.17.

Lumentum Stock Performance

Shares of Lumentum stock opened at $585.57 on Monday. The firm has a market cap of $53.11 billion, a price-to-earnings ratio of -7.44 and a beta of 1.64. The stock’s 50-day moving average is $881.57 and its 200-day moving average is $803.93. Lumentum has a one year low of $215.35 and a one year high of $1,143.00. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.61 and a quick ratio of 1.27.

Insider Activity at Lumentum

In related news, insider Yuen Wupen sold 1,500 shares of Lumentum stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $827.82, for a total value of $1,241,730.00. Following the sale, the insider owned 100,434 shares of the company’s stock, valued at approximately $83,141,273.88. The trade was a 1.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Michael E. Hurlston sold 548 shares of the company’s stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $958.66, for a total value of $525,345.68. Following the sale, the chief executive officer owned 186,951 shares in the company, valued at $179,222,445.66. The trade was a 0.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 94,496 shares of company stock worth $85,978,498. Corporate insiders own 0.28% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Private Advisor Group LLC boosted its holdings in shares of Lumentum by 322.7% in the 3rd quarter. Private Advisor Group LLC now owns 7,389 shares of the technology company’s stock valued at $7,177,000 after buying an additional 5,641 shares during the last quarter. Focus Advisor Solutions LLC increased its holdings in Lumentum by 120.3% during the third quarter. Focus Advisor Solutions LLC now owns 2,934 shares of the technology company’s stock worth $2,850,000 after buying an additional 1,602 shares during the last quarter. Independent Advisor Alliance increased its holdings in Lumentum by 53.6% during the third quarter. Independent Advisor Alliance now owns 1,792 shares of the technology company’s stock worth $1,631,000 after buying an additional 625 shares during the last quarter. Bogart Wealth LLC increased its holdings in Lumentum by 1,415.4% during the third quarter. Bogart Wealth LLC now owns 197 shares of the technology company’s stock worth $191,000 after buying an additional 184 shares during the last quarter. Finally, Prasad Wealth Partners LLC bought a new stake in shares of Lumentum in the 3rd quarter valued at about $412,000. Institutional investors and hedge funds own 94.05% of the company’s stock.

Lumentum News Summary

Here are the key news stories impacting Lumentum this week:

• Positive Sentiment: Sanford C. Bernstein raised its price target to $700 from $635 and maintained an “outperform” rating, implying potential upside from the cited share price. Analyst rating
• Positive Sentiment: Lumentum joined a broader optical-stock rebound on Nov. 9, with reports pointing to continued investor interest in AI-related photonics companies. This offers supportive sector context, though it predates the latest session. Optical stocks rebound
• Neutral Sentiment: A shareholder-law firm announced an investigation involving Lumentum, but the notice provides no specific allegations or findings. The announcement introduces uncertainty but does not establish wrongdoing. Investigation notice
• Neutral Sentiment: A report listed short interest at zero shares as of Nov. 10, despite describing it as a significant increase. Because those details conflict, the figure offers no reliable indication of short-selling pressure.
• Negative Sentiment: UBS cut its price target to $686 from $960 and shifted to a “neutral” rating, signaling a more cautious view of Lumentum’s prospects. UBS rating
• Negative Sentiment: Coverage of the proposed Marvell deal says Marvell’s share-price decline has lowered the implied value of its all-stock offer for Lumentum. That makes the deal’s consideration a potential source of pressure and uncertainty for LITE investors. Marvell deal analysis

Lumentum Company Profile

Lumentum Holdings Inc. develops and manufactures optical and photonic products used in communications networks and industrial applications. Its offerings include optical components, modules and lasers that help transmit and process data across telecommunications and data center networks. The company also supplies lasers and related technologies for industrial uses, including precision manufacturing and semiconductor production. Its products serve customers in markets around the world. Lumentum became an independent public company in 2015 through a spin-off from JDSU, now Viavi Solutions.